These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20074084)

  • 21. IL-2 therapy provides no clinical benefit to HIV-infected patients on ART.
    Clin Infect Dis; 2009 Apr; 48(8):iii. PubMed ID: 19301459
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of hepatitis C and hepatitis G virus co-infection on viral and cellular dynamics in patients infected with human immunodeficiency virus following interruption of highly active anti-retroviral therapy.
    Soriano-Sarabia N; Abad MA; Vallejo A; Gutiérrez S; Leal M
    Clin Microbiol Infect; 2006 Mar; 12(3):290-3. PubMed ID: 16451419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment.
    Killian MS; Fujimura SH; Hecht FM; Levy JA
    AIDS; 2006 Jun; 20(9):1247-52. PubMed ID: 16816552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV surveillance, public health, and clinical medicine--will the walls come tumbling down?
    Fairchild AL; Bayer R
    N Engl J Med; 2011 Aug; 365(8):685-7. PubMed ID: 21864165
    [No Abstract]   [Full Text] [Related]  

  • 25. MMP-7 promoter polymorphisms do not influence CD4+ recovery and changes in plasma viral load during antiretroviral therapy for HIV-1 infection.
    Lugli E; Pinti M; Nasi M; Troiano L; Prada N; Mussini C; Borghi V; Esposito R; Cossarizza A
    Int J Immunogenet; 2005 Oct; 32(5):269-71. PubMed ID: 16164692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Commentary: Operational Guidance in the 2013 WHO consolidated antiretroviral guidelines.
    Assefa Y; Pillay Y; Van Damme W
    AIDS; 2014 Mar; 28 Suppl 2():S171-3. PubMed ID: 24849477
    [No Abstract]   [Full Text] [Related]  

  • 28. HIV doctors may treat all infected, adding thousands.
    AIDS Read; 2008 Dec; 18(12):592-3. PubMed ID: 19123254
    [No Abstract]   [Full Text] [Related]  

  • 29. Simple methods on supporting ARV therapy services.
    Djauzi S
    Acta Med Indones; 2008 Apr; 40(2):53-4. PubMed ID: 19054880
    [No Abstract]   [Full Text] [Related]  

  • 30. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study.
    Wolbers M; Bucher HC; Furrer H; Rickenbach M; Cavassini M; Weber R; Schmid P; Bernasconi E; Hirschel B; Battegay M;
    HIV Med; 2008 Jul; 9(6):397-405. PubMed ID: 18410354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Semen characteristics in human immunodeficiency virus (HIV)- and hepatitis C (HCV)-seropositive males: predictors of the success of viral removal after sperm washing.
    Garrido N; Meseguer M; Remohí J; Simón C; Pellicer A
    Hum Reprod; 2005 Apr; 20(4):1028-34. PubMed ID: 15608027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.
    Orrell C; Harling G; Lawn SD; Kaplan R; McNally M; Bekker LG; Wood R
    Antivir Ther; 2007; 12(1):83-8. PubMed ID: 17503751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sudan and Djibouti are the first ERM beneficiaries from HIV/AIDS treatment initiative.
    Ann Saudi Med; 2004; 24(2):151. PubMed ID: 15323282
    [No Abstract]   [Full Text] [Related]  

  • 36. WHO clinical criteria-based initiation of antiretroviral therapy: lessons from rural district hospitals in Cameroon with regard to 2009 revised WHO recommendations.
    Kouanfack C; Laborde-Balen G; Aghokeng AF; Bourgeois A; Dontsop M; Mben JM; Kazé S; Mpoudi-Ngolé E; Koulla-Shiro S; Delaporte E; Laurent C;
    Trop Med Int Health; 2010 May; 15(5):580-3. PubMed ID: 20214755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD4 measurements in patients with HIV: are they feasible for poor settings?
    Bentwich Z
    PLoS Med; 2005 Jul; 2(7):e214; quiz e254. PubMed ID: 16008500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Getting smarter--the toxicity of undertreated HIV infection.
    Currier JS; Baden LR
    N Engl J Med; 2006 Nov; 355(22):2359-61. PubMed ID: 17135590
    [No Abstract]   [Full Text] [Related]  

  • 39. Are antiretrovirals enough for people living with HIV?
    Phillips A; Baker J; Lundgren J
    Lancet; 2013 Nov; 382(9903):1466-7. PubMed ID: 24182530
    [No Abstract]   [Full Text] [Related]  

  • 40. A wake-up call for global access to salvage HIV drug regimens.
    Mills EJ; Nachega JB
    Lancet; 2007 Dec; 370(9603):1885-7. PubMed ID: 18068497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.